Journal of Clinical Toxicology
Open Access
ISSN: 2161-0495
ISSN: 2161-0495
Physical Education Institute, Jimei University, Fujian, China
Research Article
The Efficacy of Shenyankangfu Tablets Combined With Losartan Potassium for Chronic Glomerulonephritis: A Systematic Review and Meta-Analysis
Author(s): Yang Yang, Jiahui Jin, Yaxin Gao, Dandan Zhu, Heting Zhang, Yuqing Xue, Hongwu Wang and Tieniu Zhao*
Objective: To conduct a systematic review of the efficacy and safety of Shenyankangfu tablets combined with losartan potassium in the treatment of chronic glomerulonephritis.
Method: Through searching CNKI, VIP, Wanfang, Chinese Biomedical Literature Service System, American Clinical Trial Registry, Embase, Web of Science, PubMed, and Cochrane Library databases. The retrieval time was from the establishment of the database to June 1, 2023. All the Randomized Controlled Trials (RCTS) of Shenyankangfu tablets combined with losartan potassium in the treatment of renal chronic glomerulonephritis were collected, and the data of clinical studies meeting the inclusion criteria was extracted. Meta-analysis was performed using Review Manager 5.4 software. The study was registered with PROSPERO, CRD42024499186.
Results: .. View More»
DOI:
10.35841/2161-1017.24.14.566